Error: Could not add to watchlist. X

AV Therapeutics Inc

+ Watchlist
CACT:US
Ticker Change
CACT:US has changed to a new ticker symbol
USD
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
AV Therapeutics, Inc. is engaged in the business of developing Cancer therapeutics and immunotherapeutic vaccines that can be used together with prevalent treatment modalities such as chemotherapy and radiation to treat active disease and to prevent metastases and recurrence.
ADDRESS
20 East 68th Street, Suite 204
New York, NY 10065
United States
PHONE
-
  • Abraham Mittelman
    Chairman/President/CEO/CFO
  • Robert Pollock
    Chief Operating Officer
  • Raj Kumar Tiwari
    Chief Scientific Officer
  • Morton Coleman
    Vice President
  • Jan Geliebter
    Secretary
Show More